Great Content from the Advances in Genome Biology and Technology (AGBT) Conference

by jtaylor on March 2, 2010

http://www.flickr.com/photos/shaury/ / CC BY-SA 2.0

The annual Advances in Genome Biology and Technology (AGBT) conference is ‘the’ place to be to see the latest and greatest in new DNA sequencing technologies.  This year was no exception, with all the major and emergent sequencing companies like Roche Applied Science, Life Technologies, Illumina, Pacific Biosystems, Complete Genomics, Helicos, and Ion Torrent in attendance. For those of us not fortunate enough to learn about the latest feats of sequencing while enjoying the sun of Marco Island, there was still a copious amount of information streaming live from the AGBT conference. I followed the meeting very closely via twitter (search AGBT) and found it really cool just how much information was being translated from the participants.  In addition,  many of these folks posted very informative blogs on the announcements, talks, and sentiment of the conference.  Here I’ve summarized some of the good posts I’ve collected, which you can also see on my delicious account.  The folks writing the blogs I picked up include Anthony Fejes of the University of British Columbia, Dan Koboldt of the Washington University in St. Louis Genome Sequencing Center, Daniel MacArthur and Luke Jostins of the Wellcome Trust Sanger Institute, Kevin Davis of BioIT World.  Summary:

Conference and sequencing technology overviews read: this summary of the conference (Anthony) with full notes full notes (Anthony), or these great overviews of the technologies here (Daniel) and here (Luke).

Complete Genomics: interview (Anthony)

IonTorrent: analysis (Dan)

Pacific Biosciences: indepth overview’s of PacBio’s new machine here (Kevin), here (Dan), and here (Daniel).

Please let me know what posts I’ve missed.  I can’t seem to find a good (and subscription free) analysis of Life Technology’s or Helicos’ presence.

Thanks everyone for the analysis.  For anyone that hasn’t read through the posts, it’s well worth it. The sequencing space becomes more and more interesting every day and is on track to make an even greater impact in science and health than it did in the last decade.

NOTE: After submitting this post, Luke Jostins informative analysis of the presented 3rd generation sequencers. This includes products from Life Technologies, Pacific Biosciences, and Oxford Nanopore.

  • http://www.bioventurist.com jtaylor

    After submitting this post, Luke Jostins informative analysis of the presented 3rd generation sequencers (http://www.genetic-inference.co.uk/blog/?p=839). This includes products from Life Technologies, Pacific Biosciences, and Oxford Nanopore.

  • http://www.persistentchange.com/technology/companies-developing-dna-sequencer-instruments-services/ DNA Sequencing Companies

    [...] For those who haven’t been to the BioVenturist, a short background is in order.  The BioVenturist is a free open source platform for conducting biotechnology research and analysis that my partner, Ben Good, and I have developed over the past year.  The database is free, open, and community driven, with the backend relying on the Freebase semantic-web platform.  The database has a significant focus on companies, diseases, and technology types, and you can interact with the data using filtered searches.  For instance, here’s a list of companies using genomic technologies.  Development for this project is ongoing and we are in the process of allowing users to edit information on the BioVenturist site and intend to create an embeddable blog widget to display such information. In any case, please let me know if there are additional sequencing or genomics companies I should add to this list.  Also, we are always looking for folks to help us add data and/or code.  Contact me if interested. – To read some good analysis on DNA sequencing companies, check out: – Dan Koboldt on the Fragmentation of Sequencing Market – My previous post which summarizes analysis from the AGBT Conference [...]

Previous post:

Next post: